Pharmafile Logo
Pharmafocus logo
Advanced Search
merckincweb

MSD shuts down Phase 3 trial in prodromal Alzheimer’s

February 14, 2018
Research and Development Alzheimer's, MSD, pharma, verubecestat

Another blow has been dealt to the field of Alzheimer’s research as MSD announces yet another trial failure of a …

News
finland_flag

Pfizer taps real world evidence for CVD in new partnership

February 14, 2018
Research and Development BC Platforms, Pfizer, biotech, cardiovascular disease, drugs, pharma, pharmaceutical

BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer …

News

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018
Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …

News
shutterstock_273326141

Roivant signs $600m licensing deal with Poxel

February 13, 2018
Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma

Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …

News
cell-3089947_960_720

Vertex gets approval for combo-therapy in cystic fibrosis

February 13, 2018
Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …

News
jason_drees_arizona_state_university

Cancer-targeting nanorobots successfully starve and shrink tumours, study shows

February 13, 2018
Manufacturing and Production, Research and Development Arizona State university, Cancer, Chinese Academy of Sciences, National Center for Nanoscience and Technology, nanorobots, pharma

A team of researchers from Arizona State University (ASU), in partnership with the Chinese Academy of Sciences’ National Center for …

News
pills-384846_960_720

Purdue pulls plug on opioid marketing

February 13, 2018
Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …

News
flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

News
network-1989146_960_720

Taking a look behind the scenes of Serialisation

February 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation

The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …

Feature

NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma

February 12, 2018
Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma

Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …

News

Sanofi in $155m influenza vaccine deal

February 12, 2018
Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical

Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …

News

Novo’s Ozempic secures European approval in type 2 diabetes

February 12, 2018
Sales and Marketing EC, EMA, Europe, Novo Nordisk, diabetes, pharma

Novo Nordisk has revealed that its drug Ozempic (semaglutide) has received approval from the European Commission (EC) as a monotherapy …

News

Trump’s drug pricing reforms lack bite

February 12, 2018
Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …

News
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018
Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …

News
david_kendall

MannKind entices Lilly VP to CMO role

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical

MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …

Appointment
gsk_wall

SFO bribery investigation into GSK opens old wounds

February 9, 2018
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma

It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …

News
fuji

Fujifilm partners with Takeda, stepping into regenerative medicine

February 9, 2018
Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical

Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …

News

FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer

February 9, 2018
Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma

Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …

News
teva_copy

Migraine drug bad news hits a weakened Teva

February 9, 2018
Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026